The evidence behind Phase

Grounded in the research — not internet folklore.

The low-FODMAP diet is one of the most-studied dietary therapies in gastroenterology. Here's what the clinical evidence actually shows — and exactly how Phase turns that research into the food decisions you make every day.

Private beta · iPhone

Be first to try Phase.

Phase is in private beta on iPhone. Drop your email and we'll send your invite the moment a spot opens — plus a heads-up when Android lands. It's free during beta.

We'll only email you about Phase. Unsubscribe anytime.

Explore the food data
A research notebook beside fresh apple, spring onions and grapes in soft natural light

~50% lower

IBS symptom scores

In Monash's landmark 2014 feeding trial, gut symptom scores roughly halved on a low-FODMAP diet versus a typical diet.2

Ranked #1

dietary therapy for IBS

A 2022 network meta-analysis in Gut placed the low-FODMAP diet first for global symptoms among all diets studied.3

Up to 3 in 4

people feel relief

Monash reports meaningful symptom improvement in up to three-quarters of people with IBS who follow the diet.1

What the evidence says

A protocol built on peer-reviewed trials.

The low-FODMAP diet was developed at Monash University in Melbourne, with the first research published in 2005 by gastroenterologist Peter Gibson and dietitians Sue Shepherd and Jane Muir.1 FODMAP stands for Fermentable Oligosaccharides, Disaccharides, Monosaccharides And Polyols — a family of short-chain carbohydrates, grouped for everyday use into fructose, lactose, fructans, GOS, and polyols.

In the landmark 2014 single-blind crossover trial, people with IBS ate provided diets for three weeks each. Overall gut-symptom scores were roughly half as severe on the low-FODMAP diet as on a typical diet (22.8 vs 44.9 on a 100-point scale).2 A 2016 meta-analysis found consistently reduced symptom severity and improved quality of life,4 and a 2022 network meta-analysis in Gut — pooling 13 randomized trials — ranked the low-FODMAP diet first among all dietary therapies for global IBS symptoms.3

That's an unusually strong evidence base for a dietary intervention — which is exactly why we built Phase on this protocol rather than a generic “trigger foods” list.

The mechanism

Why FODMAPs actually cause symptoms.

It isn't an allergy or an intolerance in the usual sense. The trigger is physical.5,7Studies show it's the gut's sensitivity to being stretched — not the sheer volume of gas — that produces symptoms in IBS.6

  1. 01

    Water in

    FODMAPs are poorly absorbed and osmotically active — they draw extra water into the small intestine.

  2. 02

    Gas up

    Reaching the colon, they're rapidly fermented by gut bacteria, producing hydrogen and methane gas.

  3. 03

    Distension → symptoms

    The added water and gas stretch the bowel. In a sensitive gut, that distension registers as pain and bloating.

This is also why serving size matters so much: the same food can be comfortable in a small portion and symptomatic in a large one, because FODMAPs stack across a meal.

A protocol, not a restriction

The goal is the fewest restrictions, not the most.

Staying in strict elimination isn't the win — and it isn't harmless. Prolonged restriction lowers beneficial gut bacteria and narrows nutrition,7 which is why reintroduction and personalization are the whole point.8 Most apps stop at elimination. Phase walks you all the way through.

  1. 012–6 weeks

    Eliminate

    Temporarily lower all high-FODMAP foods to calm symptoms and establish a clear baseline. This phase is diagnostic — never meant to be permanent.

  2. 026–8 weeks

    Reintroduce

    Systematically re-challenge one FODMAP group at a time, at rising doses, to find exactly which ones — and how much — your gut can handle.

  3. 03Ongoing

    Personalize

    Build the least-restrictive long-term diet that keeps you comfortable, restricting only what you actually react to.

Apple and red onion pieces on a kitchen scale beside a notebook of measured values

Where our data comes from

Lab-measured values, not guesswork.

FODMAP content is measured in the laboratory — foods are analyzed per gram and classified against validated low, moderate, and high serving cutoffs.12It's why a food can be green at one serving and red at another.

  • Sourced from the research. Ratings are drawn from peer-reviewed FODMAP studies and laboratory food-composition data — the same evidence base clinicians use.

  • Serving thresholds, per food. Every food carries the serving size where it tips from low to high — because the dose is what triggers symptoms, not the food itself.

  • Transparent confidence. Each rating shows how it was verified and how confident it is. When a food can't be matched, Phase says so instead of guessing.

Browse the 1,000+ food database

Science, in your pocket

How Phase turns the research into daily decisions.

Evidence only helps if you can act on it at the grocery store and the dinner table. That translation is what Phase is for.

Scan any food

The research tells us which FODMAPs matter. Phase checks a barcode, photo, or menu against that data and flags hidden ones like inulin, garlic powder, and high-fructose corn syrup.

See the scanner

Check the exact serving

Because dose is everything, every food page shows the low, moderate, and high serving thresholds — pulled from the same lab-measured database.

See the food list

Guided reintroduction

Phase runs the structured re-challenge the protocol calls for — one FODMAP group at a time, at escalating doses, with symptom check-ins.

See the method

Your personal tolerance map

The evidence says the diet should end in personalization. Phase turns your results into a map of how much of each FODMAP group you can eat comfortably.

See how it works

Endorsed by clinical guidelines

Recommended by the bodies that set the standards.

2021

American College of Gastroenterology

Recommends a limited trial of a low-FODMAP diet to improve global IBS symptoms.9

2016

British Dietetic Association

Positions the low-FODMAP diet as an evidence-based second-line dietary therapy, delivered by a trained dietitian.10

2015

NICE (UK)

Advises the diet be guided by a healthcare professional with expertise in dietary management of IBS.11

Honest about the limits

What the diet — and Phase — can't do.

Credibility means being straight about the caveats:

  • It manages symptoms — it isn't a cure

    IBS is a long-term condition. The diet reduces symptoms; it doesn't remove the underlying sensitivity.

  • It's not first-line for everyone

    Guidelines place it after general diet and lifestyle advice, and the overall quality of evidence is rated low — real, but not a guarantee for every person.

  • Elimination shouldn't be prolonged

    The strict phase can reduce beneficial gut bacteria and narrow nutrition. It's a diagnostic step, not a destination.

  • It works best with a dietitian

    Phase supports your care and keeps a clear record — but for diagnosis and the elimination phase, a FODMAP-trained clinician is the gold standard. Phase isn't a substitute for medical advice.

References

  1. 1.Gibson PR (2017). History of the low FODMAP diet. Journal of Gastroenterology and Hepatology, 32(S1), 5–7. doi.org/10.1111/jgh.13685
  2. 2.Halmos EP, Power VA, Shepherd SJ, Gibson PR, Muir JG (2014). A diet low in FODMAPs reduces symptoms of irritable bowel syndrome. Gastroenterology, 146(1), 67–75. doi.org/10.1053/j.gastro.2013.09.046
  3. 3.Black CJ, Staudacher HM, Ford AC (2022). Efficacy of a low FODMAP diet in irritable bowel syndrome: systematic review and network meta-analysis. Gut, 71(6), 1117–1126. doi.org/10.1136/gutjnl-2021-325214
  4. 4.Marsh A, Eslick EM, Eslick GD (2016). Does a diet low in FODMAPs reduce symptoms associated with functional gastrointestinal disorders? A systematic review and meta-analysis. European Journal of Nutrition, 55(3), 897–906. doi.org/10.1007/s00394-015-0922-1
  5. 5.Ong DK, Mitchell SB, Barrett JS, et al. (2010). Manipulation of dietary short chain carbohydrates alters the pattern of gas production and genesis of symptoms in irritable bowel syndrome. Journal of Gastroenterology and Hepatology, 25(8), 1366–1373. doi.org/10.1111/j.1440-1746.2010.06370.x
  6. 6.Major G, Pritchard S, Murray K, et al. (2017). Colon hypersensitivity to distension, rather than excessive gas production, produces carbohydrate-related symptoms in IBS. Gastroenterology, 152(1), 124–133. doi.org/10.1053/j.gastro.2016.09.062
  7. 7.Staudacher HM, Lomer MCE, Farquharson FM, et al. (2017). A diet low in FODMAPs reduces symptoms in IBS and a probiotic restores Bifidobacterium species: a randomized controlled trial. Gastroenterology, 153(4), 936–947. doi.org/10.1053/j.gastro.2017.06.010
  8. 8.Whelan K, Martin LD, Staudacher HM, Lomer MCE (2018). The low FODMAP diet in the management of IBS: an evidence-based review of restriction, reintroduction and personalisation. Journal of Human Nutrition and Dietetics, 31(2), 239–255. doi.org/10.1111/jhn.12530
  9. 9.Lacy BE, Pimentel M, Brenner DM, et al. (2021). ACG Clinical Guideline: Management of Irritable Bowel Syndrome. American Journal of Gastroenterology, 116(1), 17–44. doi.org/10.14309/ajg.0000000000001036
  10. 10.McKenzie YA, Bowyer RK, Leach H, et al. (2016). British Dietetic Association evidence-based guidelines for the dietary management of IBS in adults (2016 update). Journal of Human Nutrition and Dietetics, 29(5), 549–575. doi.org/10.1111/jhn.12385
  11. 11.National Institute for Health and Care Excellence (2008, upd. 2015). Irritable bowel syndrome in adults: diagnosis and management (CG61). NICE guideline. www.nice.org.uk/guidance/cg61
  12. 12.Varney J, Barrett J, Scarlata K, Catsos P, Gibson PR, Muir JG (2017). FODMAPs: food composition, defining cutoff values and international application. Journal of Gastroenterology and Hepatology, 32(S1), 53–61. doi.org/10.1111/jgh.13698

This page is educational and not medical advice. Talk to a doctor or registered dietitian before starting the low-FODMAP diet, especially the elimination phase.

Frequently asked

Straight answers on the science.

Is the low-FODMAP diet actually backed by science?+

Yes. It was developed by researchers at Monash University and has been tested in randomized controlled trials and meta-analyses. A 2022 network meta-analysis in Gut ranked it first among dietary therapies for global IBS symptoms. It's endorsed as an evidence-based option by the American College of Gastroenterology and the British Dietetic Association.

How well does it work?+

In the landmark 2014 Monash trial, IBS symptom scores roughly halved on a low-FODMAP diet versus a typical diet. Monash reports that up to 3 in 4 people with IBS feel meaningful relief. Response is individual — the point of the diet is to find your own tolerances, not to stay restricted.

Is it a cure for IBS?+

No. The low-FODMAP diet manages symptoms; it doesn't cure IBS. Clinical guidelines position it as a structured trial, and the restrictive first phase is meant to be temporary — you reintroduce foods to build the least-restrictive diet that keeps you comfortable.

Do I still need a dietitian if I use Phase?+

Where possible, yes — NICE and the BDA recommend the diet be guided by a clinician with FODMAP expertise, especially during elimination. Phase is built to support that care, not replace it: it makes day-to-day execution easier and gives your dietitian a clear record to work from.

Where does Phase's FODMAP data come from?+

From peer-reviewed FODMAP research and laboratory-measured food composition, with serving-size thresholds applied per food. Every rating shows how it was verified and how confident it is — and when a food can't be matched, Phase tells you rather than guessing.

Put the science to work.

Phase brings the research to every meal — free during the iPhone beta.

Private beta · iPhone

Be first to try Phase.

Phase is in private beta on iPhone. Drop your email and we'll send your invite the moment a spot opens — plus a heads-up when Android lands. It's free during beta.

We'll only email you about Phase. Unsubscribe anytime.